SlideShare a Scribd company logo
1 of 17
The Induction of PU.1 in IL-1-induced Myeloid
Differentiation
Gena V. Topper
Passegué Lab
Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF
University of California, San Francisco
Roundtable 8/6/13
Granulocyte/
Macrophage
Progenitor (GMP)
Multipotent progenitor (MPP)
Common
Lymphoid
Progenitor (CLP)
Hematopoietic Stem Cell (HSC)
RBC
Meg
Platelets
Neu Eo Bas
Mon
Mac
T cell B cell NK cell
Common Myeloid
Progenitor (CMP)
Megakaryocyte/
Erythrocyte
Progenitor (MEP)
Hematopoiesis is the process of blood generation from HSCs
Specialization
Self-renewal
• Quiescent
• Generates all blood lineages
• High self-renewal capacity
• Compartment of amplification
• Very proliferative
• Progressively more defined
lineage potential
• Terminally differentiated
• Most specialized and common,
bulk of blood system
Current and Emerging Views of Myelopoiesis
• Classical view: a process controlled by sequential activation of lineage-specific
transcription factors
• This view ignores the potential of the microenvironment and/or systemic cytokine
environment to influence the outcome/direction of HSC differentiation
• Can cell-extrinsic factors alter HSCs fate choices to facilitate myeloid
differentiation?
HSC
PU.1
PU.1
PU.1PU.1, NF-κB, C/EBPα
The Role of IL-1 in Myelopoiesis
• IL-1 is a protypical proinflammatory cytokine known to regulate myelopoiesis
• IL-1 therapy given to sublethally irradiated mice resulted in faster recovery
of the myeloid compartment, but a smaller number of pre-B and lymphoid
cells (Morrissey, et al. 1988)
• IL-1 known to drive expansion of myeloid cells in BM progenitors through
autocrine GM-CSF signaling (Bot, et al. 1990)
• HSC and MPP proliferation in response to alum-induced inflammation has
been shown to be IL-1R-dependent (Ueda, et al. 2009)
• IL-1 is an extrinsic signal that promotes myelopoiesis, but by what
mechanism?
IL-1 Signaling Affects HSC Maturation in vitro
*** p<0.005
Methocult
IL-1β Accelerates HSC differentiation in vitro
%Mac1+/FcRγ+
Mac1
Fc Rγ
-IL-1β
Days
-IL-1β
+IL-1β
%Sca1+/c-Kit+
0
25
50
75
100
0 2 4 6 8 10 12
*
*
Days
0
20
40
60
80
100
0 2 4 6 8 10 12
*
*
c-Kit
Sca1
+IL-1β
-IL-1β
+IL-1β
-IL-1β
+IL-1β
Day 1 Day 4 Day 8
Day 1 Day 4 Day 8
12 0
87
1 0
396
1 5
904
1 47
448
13 84
21
29 65
32
HSCs
24
hrs
Analysis
+/- IL-1β
1
8 19
667
5 47
3611
87 6
07
69 7
24 0
1
28 2
69
28 1
170
1
PU.1 is upregulated by IL-1β in HSCs
Is IL-1 altering
expression of myeloid
lineage determinants?
12h Liquid culture +/- IL-1β
0
0.5
1
1.5
2
2.5
Pu.1
Expression(Log2)vs.-IL-1β
C/ebpα
HSCs
24 hrs
Analysis
+/- IL-1β
eYFPPu.1
Pu.1-EYFP expression in HSCs
24hrsinculture+IL-1β
-IL-1β
+IL-1β
FITC, Living Cells
Methocult
PU.1 is a Potent Transcription Factor
• Transcription factor that mediates
myeloid and B cell differentiation
• Pu.1 expression increases as HSCs
differentiate along the myeloid axis
• PU.1 drives a molecular program
characterized by the induction of
myeloid determinants such as CD18,
CSFRs, Mac1, etc
• Pu.1 hypomorphs show impaired
myeloid differentiation
Friedman AD (2007), Oncogene
IL-1β Upregulates PU.1 Target Genes in HSCs
0
2
4
6
8
Pu.1 Mcsfr Gmcsfr
RelativeExpressionValue(Log2vs.-IL-1)β
Mcsf Gmcsf IL-6
0
2
4
6
8
*
RelativeExpressionValue(Log2vs.-IL-1)β
Methocult
IL-1-driven PU.1 Expression is Sustained in HSCs
-IL-1β
+IL-1β
Days
MFI(x102
)
MFI of PU.1 FITC
0
5
10
15
0 2 4 6
HSCs
24 hrs
Analysis
+/- IL-1β
eYFPPu.1
Number
PU.1 FITC
Day 2Day 1 Day 4 Day 6
-IL-1β
+IL-1β
IL-1 Drives PU.1 Expression in HSCs but not in Populations
that are Already Committed
Pu.1
Expression(Log2)VS.-IL-1β
HSC GMP
-1
0
1
2
3 Pu.1-EYFP expression in GMPs
24hrsinculture+/-IL-1β
FITC, Living Cells
HSCs
24 hrs
Analysis
+/- IL-1β
eYFPPu.1
Methocult
-IL-1β
+IL-1β
IL-1-driven PU.1 Expression is Minimal in GMPs
-IL-1β
+IL-1β
Days
MFI(x103
)
MFI of PU.1 FITC
0
1
2
3
0 2 4 6
GMPs
24 hrs
Analysis
+/- IL-1β
eYFPPu.1
Number
PU.1 FITC
-IL-1β
+IL-1β
Day 2Day 1 Day 4 Day 6
HSC
IL-1
IL-1RI
M-CSFR
Mac-
1
FCgR
GM-
CSFR
Pu.1 Pu.1 Division Division
GM-“primed” HSC
GM Progenitors GM
Cells
Conclusions
• Extrinsic signals are capable of altering HSC fate
• IL-1 directly activates a GM differentiation program in HSCs characterized
by increased expression of PU.1 and its downstream target genes
• Restricted to only the most immature HSC compartments as GMPS are not
responsive to Il-1 in this way
HSC
IL-1
IL-1RI
M-CSFR
Mac-
1
FCgR
GM-
CSFR
Pu.1 Pu.1 Division Division
GM-“primed” HSC
GM Progenitors GM
Cells
Future Questions
1. To what extent does IL-1 drive PU.1-dependent differentiation in
intermediate progenitor compartments?
2. Does IL-1 drive myeloid differentiation through increased expression of
cytokines such as M-CSF and GM-SCF in an autocrine loop?
Emmanuelle Passegué
Eric Pietras
Matt Warr
Stephanie Leong
Johanna Flach
Sietske Bakker
Latika Kohli
Silvia Alvarez
Cristina Mirantes-Barbeito
Acknowledgements
Thank you all for a fantastic
educational summer!!!
Have a wonderful 2013
8 19
667
5 47
3611

More Related Content

What's hot

Leukocyte disorders akk
Leukocyte disorders akkLeukocyte disorders akk
Leukocyte disorders akkAskin Kaplan
 
Red blood cell - Erythropoiesis
Red blood cell - ErythropoiesisRed blood cell - Erythropoiesis
Red blood cell - ErythropoiesisElizabeth Joseph
 
Hemopoietic growth factors
Hemopoietic growth factorsHemopoietic growth factors
Hemopoietic growth factorsPrasit Chanarat
 
Red blood cell formation and fate of RBC
Red blood cell formation and fate of RBCRed blood cell formation and fate of RBC
Red blood cell formation and fate of RBCmanojj123
 
Induction of functional hepatocyte like cells from mouse fibroblasts
Induction of functional hepatocyte like cells from mouse fibroblastsInduction of functional hepatocyte like cells from mouse fibroblasts
Induction of functional hepatocyte like cells from mouse fibroblastsShubhda Roy
 
General physiology - Genesis of blood cells
General physiology  - Genesis of blood cellsGeneral physiology  - Genesis of blood cells
General physiology - Genesis of blood cellsHamzeh AlBattikhi
 
The metabolic approach to cancer
The metabolic approach to cancerThe metabolic approach to cancer
The metabolic approach to cancerfathi neana
 
Hypoxia inducing factor-1,( HIF-1)
Hypoxia inducing factor-1,( HIF-1)Hypoxia inducing factor-1,( HIF-1)
Hypoxia inducing factor-1,( HIF-1)sainiamit22
 
Mnt for the diseases of blood and blood
Mnt for the diseases of blood and bloodMnt for the diseases of blood and blood
Mnt for the diseases of blood and bloodGerard Guillen
 
physiology of Blood and its current concepts in coagulation
physiology of Blood and its current concepts in coagulationphysiology of Blood and its current concepts in coagulation
physiology of Blood and its current concepts in coagulationDr. Akash Ardeshana
 
3.blood and its current concepts in coagulation
3.blood and its current concepts in coagulation3.blood and its current concepts in coagulation
3.blood and its current concepts in coagulationAminah M
 
Metabolic regulation at whole cell level
Metabolic regulation at whole cell levelMetabolic regulation at whole cell level
Metabolic regulation at whole cell levelSakshiAgrawal151
 

What's hot (20)

Hematopoiesis
HematopoiesisHematopoiesis
Hematopoiesis
 
Leukocyte disorders akk
Leukocyte disorders akkLeukocyte disorders akk
Leukocyte disorders akk
 
Red blood cell - Erythropoiesis
Red blood cell - ErythropoiesisRed blood cell - Erythropoiesis
Red blood cell - Erythropoiesis
 
Hematopoiesis
HematopoiesisHematopoiesis
Hematopoiesis
 
Hemopoietic growth factors
Hemopoietic growth factorsHemopoietic growth factors
Hemopoietic growth factors
 
Red blood cell formation and fate of RBC
Red blood cell formation and fate of RBCRed blood cell formation and fate of RBC
Red blood cell formation and fate of RBC
 
Poster
PosterPoster
Poster
 
Erythropoiesis
ErythropoiesisErythropoiesis
Erythropoiesis
 
Blood
Blood Blood
Blood
 
Induction of functional hepatocyte like cells from mouse fibroblasts
Induction of functional hepatocyte like cells from mouse fibroblastsInduction of functional hepatocyte like cells from mouse fibroblasts
Induction of functional hepatocyte like cells from mouse fibroblasts
 
Regulation of erytropioesis
Regulation of erytropioesisRegulation of erytropioesis
Regulation of erytropioesis
 
General physiology - Genesis of blood cells
General physiology  - Genesis of blood cellsGeneral physiology  - Genesis of blood cells
General physiology - Genesis of blood cells
 
Hemopoeitics and Heamatinics
Hemopoeitics and HeamatinicsHemopoeitics and Heamatinics
Hemopoeitics and Heamatinics
 
The metabolic approach to cancer
The metabolic approach to cancerThe metabolic approach to cancer
The metabolic approach to cancer
 
Hypoxia inducing factor-1,( HIF-1)
Hypoxia inducing factor-1,( HIF-1)Hypoxia inducing factor-1,( HIF-1)
Hypoxia inducing factor-1,( HIF-1)
 
Mnt for the diseases of blood and blood
Mnt for the diseases of blood and bloodMnt for the diseases of blood and blood
Mnt for the diseases of blood and blood
 
physiology of Blood and its current concepts in coagulation
physiology of Blood and its current concepts in coagulationphysiology of Blood and its current concepts in coagulation
physiology of Blood and its current concepts in coagulation
 
3.blood and its current concepts in coagulation
3.blood and its current concepts in coagulation3.blood and its current concepts in coagulation
3.blood and its current concepts in coagulation
 
Metabolic regulation at whole cell level
Metabolic regulation at whole cell levelMetabolic regulation at whole cell level
Metabolic regulation at whole cell level
 
Human growth factorS
Human growth factorSHuman growth factorS
Human growth factorS
 

Viewers also liked

Viewers also liked (10)

Peripheral Smear & Bone Marrow
Peripheral Smear & Bone MarrowPeripheral Smear & Bone Marrow
Peripheral Smear & Bone Marrow
 
Haemopoiesis
HaemopoiesisHaemopoiesis
Haemopoiesis
 
ALL
ALLALL
ALL
 
Haemopoiesis
HaemopoiesisHaemopoiesis
Haemopoiesis
 
Haemopoiesis
HaemopoiesisHaemopoiesis
Haemopoiesis
 
Hematopoiesis
HematopoiesisHematopoiesis
Hematopoiesis
 
Leukemia
LeukemiaLeukemia
Leukemia
 
Leukemia Powepoit Presentation
Leukemia Powepoit PresentationLeukemia Powepoit Presentation
Leukemia Powepoit Presentation
 
Leukemia
LeukemiaLeukemia
Leukemia
 
Erythropoiesis
ErythropoiesisErythropoiesis
Erythropoiesis
 

Similar to Roundtable 6-8-13mv1-3-3

59001-168_Slides.pptx
59001-168_Slides.pptx59001-168_Slides.pptx
59001-168_Slides.pptxganeshrao65
 
sodapdf-converted.pptx
sodapdf-converted.pptxsodapdf-converted.pptx
sodapdf-converted.pptxEllyanaFarina1
 
Erstressindiabeticcomplicationfinal 150505043746-conversion-gate02 (2)
Erstressindiabeticcomplicationfinal 150505043746-conversion-gate02 (2)Erstressindiabeticcomplicationfinal 150505043746-conversion-gate02 (2)
Erstressindiabeticcomplicationfinal 150505043746-conversion-gate02 (2)Basveshwar Gawali
 
ENDOPLASMIC RETICULUM STRESS IN DIABETIC COMPLICATIONS
ENDOPLASMIC RETICULUM STRESS IN DIABETIC COMPLICATIONSENDOPLASMIC RETICULUM STRESS IN DIABETIC COMPLICATIONS
ENDOPLASMIC RETICULUM STRESS IN DIABETIC COMPLICATIONSBasweshwar Gawali
 
1. Leucopoiesis - myeloid.ppt
1. Leucopoiesis - myeloid.ppt1. Leucopoiesis - myeloid.ppt
1. Leucopoiesis - myeloid.pptDaraWin1
 
Subramanian_2008-06-06.pptx
Subramanian_2008-06-06.pptxSubramanian_2008-06-06.pptx
Subramanian_2008-06-06.pptxbiswajitbhuyan14
 
Tma lecture mskcc
Tma lecture mskccTma lecture mskcc
Tma lecture mskccderosaMSKCC
 
clinicalenzymology-120625130732-phpapp02.pptx
clinicalenzymology-120625130732-phpapp02.pptxclinicalenzymology-120625130732-phpapp02.pptx
clinicalenzymology-120625130732-phpapp02.pptxDrirFaisalHasan
 
Characterization of gfp expression in lck 1 gfp transgenic mice
Characterization of gfp expression in lck 1 gfp transgenic miceCharacterization of gfp expression in lck 1 gfp transgenic mice
Characterization of gfp expression in lck 1 gfp transgenic miceAustin Nnah
 
Hypoxia inducible factor (hif)
Hypoxia inducible factor (hif)Hypoxia inducible factor (hif)
Hypoxia inducible factor (hif)DrDharmendra Singh
 
clinicalenzymology-120625130732-phpapp02.pdf
clinicalenzymology-120625130732-phpapp02.pdfclinicalenzymology-120625130732-phpapp02.pdf
clinicalenzymology-120625130732-phpapp02.pdfLeira8
 
Blood physiology seminar
Blood physiology seminarBlood physiology seminar
Blood physiology seminarmahesh kumar
 
Cardiac hypertrophy - Molecules and drugs involved
Cardiac hypertrophy - Molecules and drugs involvedCardiac hypertrophy - Molecules and drugs involved
Cardiac hypertrophy - Molecules and drugs involvedBiswajit Kalita
 

Similar to Roundtable 6-8-13mv1-3-3 (20)

Blood
BloodBlood
Blood
 
59001-168_Slides.pptx
59001-168_Slides.pptx59001-168_Slides.pptx
59001-168_Slides.pptx
 
sodapdf-converted.pptx
sodapdf-converted.pptxsodapdf-converted.pptx
sodapdf-converted.pptx
 
Erstressindiabeticcomplicationfinal 150505043746-conversion-gate02 (2)
Erstressindiabeticcomplicationfinal 150505043746-conversion-gate02 (2)Erstressindiabeticcomplicationfinal 150505043746-conversion-gate02 (2)
Erstressindiabeticcomplicationfinal 150505043746-conversion-gate02 (2)
 
ENDOPLASMIC RETICULUM STRESS IN DIABETIC COMPLICATIONS
ENDOPLASMIC RETICULUM STRESS IN DIABETIC COMPLICATIONSENDOPLASMIC RETICULUM STRESS IN DIABETIC COMPLICATIONS
ENDOPLASMIC RETICULUM STRESS IN DIABETIC COMPLICATIONS
 
1. Leucopoiesis - myeloid.ppt
1. Leucopoiesis - myeloid.ppt1. Leucopoiesis - myeloid.ppt
1. Leucopoiesis - myeloid.ppt
 
Transcription Factors
Transcription FactorsTranscription Factors
Transcription Factors
 
Subramanian_2008-06-06.pptx
Subramanian_2008-06-06.pptxSubramanian_2008-06-06.pptx
Subramanian_2008-06-06.pptx
 
Tma lecture mskcc
Tma lecture mskccTma lecture mskcc
Tma lecture mskcc
 
Clinical Enzymology
Clinical EnzymologyClinical Enzymology
Clinical Enzymology
 
clinicalenzymology-120625130732-phpapp02.pptx
clinicalenzymology-120625130732-phpapp02.pptxclinicalenzymology-120625130732-phpapp02.pptx
clinicalenzymology-120625130732-phpapp02.pptx
 
Characterization of gfp expression in lck 1 gfp transgenic mice
Characterization of gfp expression in lck 1 gfp transgenic miceCharacterization of gfp expression in lck 1 gfp transgenic mice
Characterization of gfp expression in lck 1 gfp transgenic mice
 
Hypoxia inducible factor (hif)
Hypoxia inducible factor (hif)Hypoxia inducible factor (hif)
Hypoxia inducible factor (hif)
 
clinicalenzymology-120625130732-phpapp02.pdf
clinicalenzymology-120625130732-phpapp02.pdfclinicalenzymology-120625130732-phpapp02.pdf
clinicalenzymology-120625130732-phpapp02.pdf
 
Blood physiology seminar
Blood physiology seminarBlood physiology seminar
Blood physiology seminar
 
238570.pptx
238570.pptx238570.pptx
238570.pptx
 
5. fever.pdf
5. fever.pdf5. fever.pdf
5. fever.pdf
 
Therapeutic antibodies 3_humanization
Therapeutic antibodies 3_humanizationTherapeutic antibodies 3_humanization
Therapeutic antibodies 3_humanization
 
2.g.2014-patho~ (2.adaptation-wyl)
  2.g.2014-patho~ (2.adaptation-wyl)  2.g.2014-patho~ (2.adaptation-wyl)
2.g.2014-patho~ (2.adaptation-wyl)
 
Cardiac hypertrophy - Molecules and drugs involved
Cardiac hypertrophy - Molecules and drugs involvedCardiac hypertrophy - Molecules and drugs involved
Cardiac hypertrophy - Molecules and drugs involved
 

Roundtable 6-8-13mv1-3-3

  • 1. The Induction of PU.1 in IL-1-induced Myeloid Differentiation Gena V. Topper Passegué Lab Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF University of California, San Francisco Roundtable 8/6/13
  • 2. Granulocyte/ Macrophage Progenitor (GMP) Multipotent progenitor (MPP) Common Lymphoid Progenitor (CLP) Hematopoietic Stem Cell (HSC) RBC Meg Platelets Neu Eo Bas Mon Mac T cell B cell NK cell Common Myeloid Progenitor (CMP) Megakaryocyte/ Erythrocyte Progenitor (MEP) Hematopoiesis is the process of blood generation from HSCs Specialization Self-renewal • Quiescent • Generates all blood lineages • High self-renewal capacity • Compartment of amplification • Very proliferative • Progressively more defined lineage potential • Terminally differentiated • Most specialized and common, bulk of blood system
  • 3. Current and Emerging Views of Myelopoiesis • Classical view: a process controlled by sequential activation of lineage-specific transcription factors • This view ignores the potential of the microenvironment and/or systemic cytokine environment to influence the outcome/direction of HSC differentiation • Can cell-extrinsic factors alter HSCs fate choices to facilitate myeloid differentiation? HSC PU.1 PU.1 PU.1PU.1, NF-κB, C/EBPα
  • 4. The Role of IL-1 in Myelopoiesis • IL-1 is a protypical proinflammatory cytokine known to regulate myelopoiesis • IL-1 therapy given to sublethally irradiated mice resulted in faster recovery of the myeloid compartment, but a smaller number of pre-B and lymphoid cells (Morrissey, et al. 1988) • IL-1 known to drive expansion of myeloid cells in BM progenitors through autocrine GM-CSF signaling (Bot, et al. 1990) • HSC and MPP proliferation in response to alum-induced inflammation has been shown to be IL-1R-dependent (Ueda, et al. 2009) • IL-1 is an extrinsic signal that promotes myelopoiesis, but by what mechanism?
  • 5. IL-1 Signaling Affects HSC Maturation in vitro *** p<0.005 Methocult
  • 6. IL-1β Accelerates HSC differentiation in vitro %Mac1+/FcRγ+ Mac1 Fc Rγ -IL-1β Days -IL-1β +IL-1β %Sca1+/c-Kit+ 0 25 50 75 100 0 2 4 6 8 10 12 * * Days 0 20 40 60 80 100 0 2 4 6 8 10 12 * * c-Kit Sca1 +IL-1β -IL-1β +IL-1β -IL-1β +IL-1β Day 1 Day 4 Day 8 Day 1 Day 4 Day 8 12 0 87 1 0 396 1 5 904 1 47 448 13 84 21 29 65 32 HSCs 24 hrs Analysis +/- IL-1β 1 8 19 667 5 47 3611 87 6 07 69 7 24 0 1 28 2 69 28 1 170 1
  • 7. PU.1 is upregulated by IL-1β in HSCs Is IL-1 altering expression of myeloid lineage determinants? 12h Liquid culture +/- IL-1β 0 0.5 1 1.5 2 2.5 Pu.1 Expression(Log2)vs.-IL-1β C/ebpα HSCs 24 hrs Analysis +/- IL-1β eYFPPu.1 Pu.1-EYFP expression in HSCs 24hrsinculture+IL-1β -IL-1β +IL-1β FITC, Living Cells Methocult
  • 8. PU.1 is a Potent Transcription Factor • Transcription factor that mediates myeloid and B cell differentiation • Pu.1 expression increases as HSCs differentiate along the myeloid axis • PU.1 drives a molecular program characterized by the induction of myeloid determinants such as CD18, CSFRs, Mac1, etc • Pu.1 hypomorphs show impaired myeloid differentiation Friedman AD (2007), Oncogene
  • 9. IL-1β Upregulates PU.1 Target Genes in HSCs 0 2 4 6 8 Pu.1 Mcsfr Gmcsfr RelativeExpressionValue(Log2vs.-IL-1)β Mcsf Gmcsf IL-6 0 2 4 6 8 * RelativeExpressionValue(Log2vs.-IL-1)β Methocult
  • 10. IL-1-driven PU.1 Expression is Sustained in HSCs -IL-1β +IL-1β Days MFI(x102 ) MFI of PU.1 FITC 0 5 10 15 0 2 4 6 HSCs 24 hrs Analysis +/- IL-1β eYFPPu.1 Number PU.1 FITC Day 2Day 1 Day 4 Day 6 -IL-1β +IL-1β
  • 11. IL-1 Drives PU.1 Expression in HSCs but not in Populations that are Already Committed Pu.1 Expression(Log2)VS.-IL-1β HSC GMP -1 0 1 2 3 Pu.1-EYFP expression in GMPs 24hrsinculture+/-IL-1β FITC, Living Cells HSCs 24 hrs Analysis +/- IL-1β eYFPPu.1 Methocult -IL-1β +IL-1β
  • 12. IL-1-driven PU.1 Expression is Minimal in GMPs -IL-1β +IL-1β Days MFI(x103 ) MFI of PU.1 FITC 0 1 2 3 0 2 4 6 GMPs 24 hrs Analysis +/- IL-1β eYFPPu.1 Number PU.1 FITC -IL-1β +IL-1β Day 2Day 1 Day 4 Day 6
  • 13. HSC IL-1 IL-1RI M-CSFR Mac- 1 FCgR GM- CSFR Pu.1 Pu.1 Division Division GM-“primed” HSC GM Progenitors GM Cells
  • 14. Conclusions • Extrinsic signals are capable of altering HSC fate • IL-1 directly activates a GM differentiation program in HSCs characterized by increased expression of PU.1 and its downstream target genes • Restricted to only the most immature HSC compartments as GMPS are not responsive to Il-1 in this way HSC IL-1 IL-1RI M-CSFR Mac- 1 FCgR GM- CSFR Pu.1 Pu.1 Division Division GM-“primed” HSC GM Progenitors GM Cells
  • 15. Future Questions 1. To what extent does IL-1 drive PU.1-dependent differentiation in intermediate progenitor compartments? 2. Does IL-1 drive myeloid differentiation through increased expression of cytokines such as M-CSF and GM-SCF in an autocrine loop?
  • 16. Emmanuelle Passegué Eric Pietras Matt Warr Stephanie Leong Johanna Flach Sietske Bakker Latika Kohli Silvia Alvarez Cristina Mirantes-Barbeito Acknowledgements Thank you all for a fantastic educational summer!!! Have a wonderful 2013

Editor's Notes

  1. At the top we have the typical HSC - self-renewing, quiescent, low metabolic activity, responsible for the production of all blood cells HSCs are unique given their self-renewal capacity and differentiate into progenitors Next is the compartment of amplification, which is important because HSCs are so rare This is where the more-differentiated progeny of the HSC reside – higher metabolic activity, more restricted lineage, generate only specific fully differentiated cells Which brings us to the compartment of cells that are fully specialized and differentiated, some of them unable to even replicate themselves, bulk of system
  2. Project mostly deals with myeloid differentiation Stochastic activation of specific TFs that leads to differentiation of HSCs to cell of myeloid lineage All HSCs have low levels of Pu.1, C/EBPa, etc  amounts increase as they differentiate When HSCs differentiate, we see ^ of these factors increase in expression, thought to be primary mediators --&amp;gt; affected by extrinsic sources such as autocrine/niche signaling?
  3. “one extrinsic factor that our lab has been investigating is IL-1, and previous studies have laid a solid groundwork of evidence for its study” Inflammatory cytokine known to drive myelopoiesis, extrinsic signals actually have a big and important effect
  4. “Previously, Jose Marc performed this experiment by culturing HSCs […] to observe the effects of colony formation and content with and without IL-1b” Amount of ‘mix’ colonies is a representation in immaturity so less ‘lineage’ choices have been made for each cells  nothing instructed the cell in a certain way (colonies are large and multilobed) IL-1b colonies have tightly-packed morphology, very pure, cells have been pushed to GM lineage “Clearly Il-1b pushes HSC to a mature myeloid lineage faster then without” We don’t know how IL-1 does this, so this is the question we are investigating
  5. “as a complimentary approach, we used a liquid culture assay to show the evolution of surface markers over time” consistent with previous results “this striking alteration of HSC surface markers showing the accelerated acquisition of mature markers and less of immature markers, showing that IL-1 is driving accelerated myeloid differentiation”
  6. “we first decided to look at how IL-1 was regulating the transcription of important myelopoiesis factors using qRT, and we found that Il-1 specifically upregulated PU.1 in HSCs, whereas we saw no specific effect for another TF, C/EBPa in HSCs” “in addition to this, we validated this data using the PU.1 reporter mouse”
  7. so what is PU.1? TALK ABOUT THE FIGURE!
  8. Saw Pu.1 ^ so looked at other myeloid determinants First graph are direct targets Second graph with genes shown to be downregulated without PU.1, other cytokines that drive myelopoiesis “this is evidence that Il-1 activates a specific PU.1-driven molecular program in HSCs, so does this happen in more differentiated myeloid cells?
  9. “If we look at the MFI, the brightness of the Il-1 samples is consistently higher, but they converge around day 6 as the effect of IL-1 lessens as the cells mature” “IL-1 is clearly inducing PU.1, but the induction is sustained only for awhile, leading us to the question of whether Il-1-induced PU.1 expression affects cells they are already somewhat differentiated”
  10. Pu.1 expression in myeloid progenitors is not driven by IL-1 signaling once the cell is already committed to myeloid differentiation No change at all in GMP as the effect of PU.1 is only a property of cells uncommitted to myeloid lineage High expression but no CHANGE/no PU.1 INDUCTION
  11. Values for ctrl AND il1 remain stable throughout experiment so far
  12. Il-1 doesn’t affect differentiated progenitors, and effect gets increasingly smaller along the axis
  13. demonstrated by IL-1 influencing and accelerating myeloid differentiation, by regulating specific transcription factors within the network such as PU.1, activating a specific molecular program
  14. The Sieweke lab (Nature, April 2013) was able to show that PU.1 expression is induced by M-CSF through a very potent upregulatory circuit we see increased expression of myelopoietic cytokines in our qRT-PCR data We could validate this by quantifying cytokine output by HSCs from regular and M-CSFR knock-out mice with and without IL-1 during myeloid differentiation in vitro